Press release archive - GSK
GSK announces headline results from the FIRST-ENGOT-OV44 phase III trial. Regulatory designation based on promising preliminary clinical data. Designation based on data showing …
Press releases - GSK US
GSK announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the safety of AREXVY and SHINGRIX. GSK confirmed it has reached two …
GSK announces cap of $35 per month on U.S. patient out-of …
GSK today announced it will cap out-of-pocket costs for eligible patients at no more than $35 per month for all of its asthma and chronic obstructive pulmonary disease (COPD) medicines,* the most prescribed portfolio of inhalers in the U.S. GSK is taking this action as part of its longstanding commitment to improving access to respiratory medici...
Next stage in GSK’s Zantac defense gets underway today
Jan 22, 2024 · GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. Developments in the...
GSK plc (GSK) Latest Stock News & Headlines - Yahoo Finance
Get the latest GSK plc (GSK) stock news and headlines to help you in your trading and investing decisions.
GlaxoSmithKline Latest News & Analysis - BBC News
Jan 17, 2022 · What vital life-saving medical device accounts for half of drugmaker GSK's emissions? Can the UK do 100,000 coronavirus tests a day? Find the latest GlaxoSmithKline …
GSK sees strong growth as Haleon split and vaccine drive pays off
Jan 31, 2024 · GSK beat market estimates for fourth-quarter results on Wednesday, and unveiled an upbeat forecast for 2024 and beyond on the ramp-up of its vaccines and cancer drugs pipeline, underscoring the...
GlaxoSmithKline - BBC News
Jan 17, 2022 · GlaxoSmithKline rejected three offers, saying they "undervalued" its consumer goods business. GSK aims to expand its Stevenage facility to create one of the largest life …
GSK's experimental drug shows promise in reducing severe …
May 21, 2024 · GSK's experimental drug met its primary goal of reducing asthma attacks in a late-stage trial, marking a bright spot for a treatment that the British drugmaker expects to make peak annual sales...
GlaxoSmithKline News | GSK News - NewsNow
NewsNow aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine …